Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004306 · ClinicalTrials.gov registry record
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
A clinical trial of Hereditary Ataxia, sponsored by Office of Rare Diseases (ORD).
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT00004306 is a study of Hereditary Ataxia that has completed, run by Office of Rare Diseases (ORD). The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00004306, a study of Hereditary Ataxia, has completed, sponsored by Office of Rare Diseases (ORD).
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies. II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.
Conditions Studied
Study Locations (1)
Texas
- University of Texas Medical Branch at Galveston - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 1999-11 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004306
The ClinicalTrials.gov registry entry for NCT00004306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Office of Rare Diseases (ORD), which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hereditary Ataxia appearing as the primary indexed condition, and to 0 interventions.
NCT00004306 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00004306 about?
NCT00004306 is a clinical study titled "Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)". OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies. II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.
What is the current status of trial NCT00004306?
This trial is currently completed. The enrollment target is 18 participants. The study started on 1999-11. Estimated completion is 2009-03.
What conditions does trial NCT00004306 study?
This clinical trial studies the following conditions: Hereditary Ataxia.
Who is sponsoring clinical trial NCT00004306?
This trial is sponsored by Office of Rare Diseases (ORD), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004306 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.